Xencor, Inc. (XNCR)
28.44
-0.86
(-2.92%)
USD |
NASDAQ |
Aug 26, 16:00
28.01
-0.44
(-1.53%)
After-Hours: 20:00
Xencor Profit Margin (Quarterly) : -42.42% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -42.42% |
| March 31, 2026 | -2.85K% |
| December 31, 2025 | -23.56% |
| September 30, 2025 | -28.70% |
| June 30, 2025 | -70.69% |
| March 31, 2025 | -148.6% |
| December 31, 2024 | -87.51% |
| September 30, 2024 | -432.3% |
| June 30, 2024 | -397.5% |
| March 31, 2024 | -536.6% |
| December 31, 2023 | -43.10% |
| September 30, 2023 | -41.02% |
| June 30, 2023 | -48.23% |
| March 31, 2023 | -320.4% |
| December 31, 2022 | -55.72% |
| September 30, 2022 | -120.0% |
| June 30, 2022 | -112.6% |
| March 31, 2022 | 27.60% |
| December 31, 2021 | 47.44% |
| September 30, 2021 | -204.2% |
| June 30, 2021 | 77.47% |
| March 31, 2021 | -7.32% |
| December 31, 2020 | -32.71% |
| September 30, 2020 | -35.49% |
| June 30, 2020 | -267.5% |
| Date | Value |
|---|---|
| March 31, 2020 | -24.93% |
| December 31, 2019 | -765.4% |
| September 30, 2019 | -46.99% |
| June 30, 2019 | -82.29% |
| March 31, 2019 | 71.51% |
| December 31, 2018 | -157.4% |
| September 30, 2018 | 10.85% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 24.43% |
| September 30, 2017 | |
| June 30, 2017 | -61.80% |
| March 31, 2017 | -442.1% |
| December 31, 2016 | -140.8% |
| September 30, 2016 | -103.3% |
| June 30, 2016 | 71.45% |
| March 31, 2016 | -88.22% |
| December 31, 2015 | 35.66% |
| September 30, 2015 | -286.5% |
| June 30, 2015 | -874.6% |
| March 31, 2015 | -432.2% |
| December 31, 2014 | -23.83% |
| September 30, 2014 | -740.3% |
| June 30, 2014 | -612.1% |
| March 31, 2014 | -171.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Incyte Corp. | 34.98% |
| Regeneron Pharmaceuticals, Inc. | 30.23% |
| MacroGenics, Inc. | -212.1% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -28.16% |
| Return on Assets | -19.99% |
| Return on Invested Capital | -21.22% |
| Gross Profit Margin (Quarterly) | 95.24% |
| Operating Margin (Quarterly) | -72.37% |
| Return on Net Operating Assets | -126.0% |